Literature DB >> 10515237

Serum thrombomodulin as a prognostic marker of disseminated intravascular coagulation.

N Kotajima1, T Kanda, Y Fukumura, I Kobayashi.   

Abstract

Disseminated intra-vascular coagulation (DIC) is associated with severe bleeding tendency and organ failure, the extent of which is thought to be related to the prognosis of DIC patients. Thrombomodulin (TM) is a high-affinity thrombin receptor on vascular endothelial cells. Clinical importance of soluble TM is still controversy as a diagnostic and prognostic indicator in patients with disseminated intravascular coagulation (DIC). We compared plasma levels of TM with fibrin degradation product (FDP) in patients with DIC through the clinical course. The significant elevation of circulating TM in nonsurvivors with DIC compared with survived patients with DIC(TM 3.1+/-1.52 vs 8.1+/-3.89 FU/ml), as well as FDP (12.9+/-12.12 vs 49.8+/-55.42 microg/ml) but the levels of FDP were not different between the two groups. The measurement of circulating TM was a relatively good prognostic marker of patients with DIC.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10515237

Source DB:  PubMed          Journal:  J Med        ISSN: 0025-7850


  3 in total

1.  Sepsis-associated disseminated intravascular coagulation and thromboembolic disease.

Authors:  Nicola Semeraro; Concetta T Ammollo; Fabrizio Semeraro; Mario Colucci
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-08-13       Impact factor: 2.576

2.  Multiple limb compartment syndrome as a manifestation of capillary leak syndrome secondary to metformin and dipeptidyl peptidase IV inhibitor overdose: A case report.

Authors:  Daisuke Kasugai; Kosuke Tajima; Naruhiro Jingushi; Norimichi Uenishi; Akihiko Hirakawa
Journal:  Medicine (Baltimore)       Date:  2020-07-17       Impact factor: 1.817

3.  Analysis of the association between resolution of disseminated intravascular coagulation (DIC) and treatment outcomes in post-marketing surveillance of thrombomodulin alpha for DIC with infectious disease and with hematological malignancy by organ failure.

Authors:  Noriaki Kawano; Hideo Wada; Toshimasa Uchiyama; Kazuo Kawasugi; Seiji Madoiwa; Naoki Takezako; Kei Suzuki; Yoshinobu Seki; Takayuki Ikezoe; Tsuyoshi Hattori; Kohji Okamoto
Journal:  Thromb J       Date:  2020-02-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.